Clinical trial
A Multicenter, Single-Arm Study of the Effects of Atrasentan on Spermatogenesis and Testicular Function
NCT02118714 is registered in ClinicalTrials.gov with AbbVie as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter, Single-Arm Study of the Effects of Atrasentan on Spermatogenesis and Testicular Function
- Lead sponsor
- AbbVie
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- April 6, 2015
- Completion date
- July 16, 2018
- Enrollment
- 20 (actual)
- Sites
- 13
Conditions
As the registry lists them; a condition with its own page is linked.
diabetes, nephropathy